Purified Exosome Product (PEP) Injected Into the Hypodermis

计划入组 8 人 · 首次发布于 2024 年 5 月 24 日

Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)

计划入组 59 人 · 首次发布于 2024 年 3 月 20 日

Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients

计划入组 20 人 · 首次发布于 2024 年 6 月 20 日

Purified Exosome Product (Rion)

Purified Exosome Product(Clinical Testing of Beverly Hills)

Exosome VLP vaccine

Exosome Diagnostics, Inc.

United States

KAREWAY PRODUCT INC.

United States

PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC

United States

RION Initiates Phase 1b Trial of Exosome Therapy PEP for Knee Osteoarthritis

RION Partners with Lonza to Scale Commercial Production of Platelet-Derived Exosome Therapeutics

RION Completes Enrollment for Phase 2 Clinical Study of PEP™ in Diabetic Foot Ulcers